AIkido Pharma (AIKI) Stock Highlights

3.95 | -2.47%

2023-01-26 20:58:10

AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing a antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19.

Statistics

Range Today

3.9 4.07

Volume Today 25.38K

Range 1 Year

0.29 7.27

Volume 1 Year 134.03M

Range 3 Year

0.29 7.27

Volume 3 Year 2.97B

Range 10 Year

0.29 2249.68

Volume 10 Year 3.05B

Highlights

Market Capitalization 19.53M (micro)

Floating Shares 4.38M

Current Price 3.95

Price To Earnings -1.92

Price To Book 0.22

Earnings Per Share -1.85

Payout Ratio 0%

Performance

Latest -2.47%

1 Month +18.98%

3 Months -36.19%

6 Months -30.58%

1 Year +690%

3 Years +234.75%

5 Years -33.16%

10 Years -99.2%

Benchmarks

Market Capitalization

328 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

61 / 368

Free Cashflow

121 / 352

Performance 5 years

173 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.